RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma

Adjuvant transcatheter arterial chemoembolization (TACE) protects against hepatocellular carcinoma (HCC) and is associated with reduced disease recurrence and improved outcome after surgery. However, deterioration of liver function after TACE negatively impacts the patient prognosis and limits it us...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Zhang, Jian, Jiang, Tian-Yi, Jiang, Bei-Ge, Yang, Chun, Tan, Ye-Xiong, Yang, Ning, Pan, Yu-Fei, Ding, Zhi-Wen, Yang, Guang-Zhen, Wu, Meng-Chao, Dong, Li-Wei, Wang, Hong-Yang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2014
Soggetti:
Clinical Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413664/
https://ncbi.nlm.nih.gov/pubmed/25605019
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi